What one share of Carlsmed holds
We are a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a focus on becoming the standard of care for spine fusion surgery. Our mission is to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.
Carlsmed’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $2.49 |
|---|---|
| Profit | −$1.43 |
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$1.36 |
| Cash and investments | $1.70 |
| Debt | $0.56 |
| Book value | $3.09 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | $6.68 | −$6.11 | $0.04 | −$6.31 | — | −$17.06 |
| 2025 | $3.55 | −$2.12 | $0.05 | −$2.08 | — | $3.72 |
Common questions about Carlsmed
How much does one share of Carlsmed earn?
Over the last 12 months, Carlsmed lost $1.43 for each share on $2.49 of sales.
Does Carlsmed pay a dividend?
Carlsmed didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Carlsmed’s book value per share?
Carlsmed’s book value is $3.09 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Carlsmed have?
Each share of Carlsmed has $1.70 of cash and investments and $0.56 of debt, as of June 30, 2026.
What is Carlsmed’s free cash flow per share?
−$1.36 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.